Screener
Madrigal Pharmaceuticals, Inc. MDGL Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Gross To Net Adjustments Reserve by Product | ||||||
| Chargebacks, Discounts for Prompt Pay and Other Allowances | $23.49M+449% | $20.83M+363% | $8.84M+111% | $6.06M— | $4.28M— | |
| Rebates, Co-Pay Assistance, Returns, and Other | $152.27M— | $122.73M— | $90.5M— | —— | —— |
FAQ
- How does Madrigal Pharmaceuticals, Inc. break its business down?
- Madrigal Pharmaceuticals, Inc. (MDGL) reports gross to net adjustments reserve by product across 2 parts — Chargebacks, Discounts for Prompt Pay and Other Allowances and Rebates, Co-Pay Assistance, Returns, and Other. Each is extracted from the segment footnotes and tracked over time.
- Where does Madrigal Pharmaceuticals, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Madrigal Pharmaceuticals, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
